| Senile systemic amyloidosis: clinical features at presentation and outcome JH Pinney, CJ Whelan, A Petrie, J Dungu, SM Banypersad, ... Journal of the American Heart Association 2 (2), e000098, 2013 | 424 | 2013 |
| Outcome in renal Al amyloidosis after chemotherapy JH Pinney, HJ Lachmann, L Bansi, AD Wechalekar, JA Gilbertson, ... Journal of clinical oncology 29 (6), 674-681, 2011 | 169 | 2011 |
| Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers T Lane, N Wassef, S Poole, Y Mistry, HJ Lachmann, JD Gillmore, ... Circulation research 114 (4), 672-676, 2014 | 79 | 2014 |
| 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease JK Quint, GC Donaldson, N Wassef, JR Hurst, M Thomas, JA Wedzicha BMC pulmonary medicine 12, 1-9, 2012 | 62 | 2012 |
| Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development … AD Wechalekar, JD Gillmore, N Wassef, HJ Lachmann, C Whelan, ... Haematologica 96 (7), 1079, 2011 | 48 | 2011 |
| Thyroid dysfunction in a UK hepatitis C population treated with interferon‐α and ribavirin combination therapy SJ Costelloe, N Wassef, J Schulz, T Vaghijiani, C Morris, S Whiting, ... Clinical endocrinology 73 (2), 249-256, 2010 | 45 | 2010 |
| Comparison of free light chain assays: Freelite and N latex in diagnosis, monitoring, and predicting survival in light chain amyloidosis S Mahmood, NL Wassef, SJ Salter, S Sachchithanantham, T Lane, ... American Journal of Clinical Pathology 146 (1), 78-85, 2016 | 11 | 2016 |
| A New Staging System for AL Amyloidosis Incorporating Serum Free Light Chains, cardiac Troponin-T and NT-ProBNP. AD Wechalekar, NL Wassef, SDJ Gibbs, J Gillmore, F Dike, H Lachmann, ... Blood 114 (22), 2796, 2009 | 8 | 2009 |
| Serum immunoglobulin heavy/light chain ratios (Hevylite) in patients with systemic AL amyloidosis AD Wechalekar, S Harding, HJ Lachmann, JD Gillmore, NL Wassef, ... INFORMA HEALTHCARE 17, 188-189, 2010 | 6 | 2010 |
| High early mortality and poor outcomes for patients with AL amyloidosis presenting with high serum free light chains-a new risk stratification model AD Wechalekar, N Wassef, H Lachmann, P Sattianayagam, SDJ Gibbs, ... FERRATA STORTI FOUNDATION 94, 222-222, 2009 | 3 | 2009 |
| The role of immunological assessment in patients with acute kidney injury and possible myeloma HJ Lachmann, NL Wassef Advances in Chronic Kidney Disease 19 (5), 287-290, 2012 | 2 | 2012 |
| Rise in serum NT pro-BNP associated with chemotherapy in patients with AL amyloidosis: implications for organ response assessment SDJ Gibbs, PT Sattianayagam, CJ Whelan, M De Cruz, JM Abreu, ... INFORMA HEALTHCARE 17, 179-179, 2010 | 2 | 2010 |
| Normal heavy/light chain (HLC) and free light chain (FLC) ratios are associated with prolonged survival in patients with systemic AL amyloidosis AD Wechalekar, P Young, N Wassef, JD Gillmore, SD Gibbs, JH Pinney, ... The Proceedings of XIIIth International Symposium Amyloidosis, GUARD, The …, 2012 | 1 | 2012 |
| Utility of the heavy light chain (HLC) assay in patients with AL amyloidosis with a detectable serum monoclonal protein AD Wechalekar, P Young, N Wassef, JD Gillmore, SD Gibbs, JH Pinney, ... The Proceedings of XIIIth International Symposium Amyloidosis, GUARD, The …, 2012 | 1 | 2012 |
| 103 Senile systemic amyloidosis: a common cause of heart failure in the elderly? JH Pinney, HJ Lachmann, JD Gillmore, A Wechalekar, SDJ Gibbs, ... Heart 97 (Suppl 1), A59-A60, 2011 | 1 | 2011 |
| An analysis of the Endocrine Disease associated with Systemic AL Amyloidosis S Gibbs, M Vanderpump, D Hutt, P Sattianayagam, J Pinney, N Wassef, ... FERRATA STORTI FOUNDATION 95, 393-394, 2010 | 1 | 2010 |
| Changes in serum NT-proBNP correlate with changes in both systolic and diastolic function in AL amyloidosis CJ Whelan, B Pawarova, M De Cruz, HJ Lachmann, PT Sattianayagam, ... INFORMA HEALTHCARE 17, 166-166, 2010 | 1 | 2010 |
| Thyroid dysfunction in a Hepatitis C population treated with interferon therapy S Costelloe, N Wassef, C Morris, J Schulz, T Vaghjani, M Thomas, ... Endocrine Abstracts 19, 2009 | 1 | 2009 |
| Method-related interference in thyroid function assays N Wassef, J Sheffield, L Ward, W Wassif Clinical Medicine 19 (Suppl 2), 57, 2019 | | 2019 |
| Heavy/light chain immunoparesis identifies systemic AL amyloidosis patients with poor survival outcomes S Sachchithanantham, O Berlanga, A Alvi, N Wassef, S Mahmood, ... Clinical Lymphoma, Myeloma and Leukemia 15, e192, 2015 | | 2015 |
